Lieping Chen
Impact in
- Oncology top 0.01%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 0.01%
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Immunology 209
- T-cell and B-cell Immunology 133
- Immunotherapy and Immune Responses 95
- Immune Cell Function and Interaction 9
- Immune cells in cancer 8
- Immune Response and Inflammation 6
- Oncology 141
- Cancer Immunotherapy and Biomarkers 133
- Co-authors
- Dallas B. Flies (37 shared papers)Koji Tamada (54 shared papers)Gefeng Zhu (39 shared papers)Weiping Zou (10 shared papers)Haidong Dong (17 shared papers)Miguel F. Sanmamed (17 shared papers)Drew M. Pardoll (16 shared papers)Xue Na Han (12 shared papers)
- Journals
- The Journal of Immunology (47 papers)Blood (26 papers)Clinical Cancer Research (16 papers)Journal of Clinical Investigation (14 papers)Nature Medicine (12 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Lieping Chen
362 papers receiving 77.3k citations
Lieping Chen's Hit Papers
Peers
Comparison fields: 5 of 149
- Oncology 42.1k
- Immunology 22.9k
- Otorhinolaryngology 1.1k
- Cancer Research 2.6k
- Hepatology 1.6k
Countries citing papers authored by Lieping Chen
This map shows the geographic impact of Lieping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieping Chen more than expected).
Fields of papers citing papers by Lieping Chen
This network shows the impact of papers produced by Lieping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieping Chen. The network helps show where Lieping Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lieping Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 366 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer Hit paper breakdown → | 2012 | 10619 |
| 2 | Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival Hit paper breakdown → | 2004 | 4365 |
| 3 | Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion Hit paper breakdown → | 2002 | 4289 |
| 4 | Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates Hit paper breakdown → | 2010 | 2594 |
| 5 | Molecular mechanisms of T cell co-stimulation and co-inhibition Hit paper breakdown → | 2013 | 2512 |
| 6 | B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion Hit paper breakdown → | 1999 | 2209 |
| 7 | Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy Hit paper breakdown → | 2014 | 2067 |
| 8 | PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations Hit paper breakdown → | 2016 | 2055 |
| 9 | Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape Hit paper breakdown → | 2012 | 1856 |
| 10 | Inhibitory B7-family molecules in the tumour microenvironment Hit paper breakdown → | 2008 | 1400 |
| 11 | Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future Hit paper breakdown → | 2015 | 1243 |
| 12 | A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization Hit paper breakdown → | 2018 | 1203 |
| 13 | Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity Hit paper breakdown → | 2003 | 1127 |
| 14 | Co-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity Hit paper breakdown → | 2004 | 1088 |
| 15 | Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4 Hit paper breakdown → | 1992 | 945 |
| 16 | B7-H3: A costimulatory molecule for T cell activation and IFN-γ production Hit paper breakdown → | 2001 | 898 |
| 17 | Blockade of B7-H1 and PD-1 by Monoclonal Antibodies Potentiates Cancer Therapeutic Immunity Hit paper breakdown → | 2005 | 852 |
| 18 | Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression Hit paper breakdown → | 2014 | 839 |
| 19 | Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors Hit paper breakdown → | 1997 | 797 |
| 20 | Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3 Hit paper breakdown → | 2018 | 730 |
About Lieping Chen
Lieping Chen is a scholar working on Immunology, Oncology, Hematology, Pathology and Forensic Medicine and Epidemiology, having authored 366 papers that have together received 79.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (133 papers), T-cell and B-cell Immunology (133 papers), Immunotherapy and Immune Responses (95 papers), Hematopoietic Stem Cell Transplantation (12 papers), Immune Cell Function and Interaction (9 papers), Immune cells in cancer (8 papers), Immune Response and Inflammation (6 papers) and Diabetes and associated disorders (6 papers). The work is most often cited by research in Oncology (42.1k citations), Immunology (22.9k citations), Otorhinolaryngology (1.1k citations), Cancer Research (2.6k citations) and Hepatology (1.6k citations). Lieping Chen has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Dallas B. Flies, Koji Tamada, Gefeng Zhu, Weiping Zou, Haidong Dong, Miguel F. Sanmamed, Drew M. Pardoll, Xue Na Han, Jedd D. Wolchok and Scott Eric Strome. Their work appears in journals such as The Journal of Immunology, Blood, Clinical Cancer Research, Journal of Clinical Investigation and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.